News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioOutsource To Open New Biosimilar Centre Of Excellence In Glasgow As Global Demand Surges


2/5/2014 6:02:39 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Glasgow, Scotland, February 5, 2014 / B3C newswire / – BioOutsource Ltd. (“BioOutsource”), a global leader in biologics contract testing and biosimilar characterization for the biopharmaceutical industry, today announced the opening of a new Biosimilar Centre of Excellence in Glasgow. The new facility will double the company’s capacity for the analysis of biosimilar monoclonal antibodies.

“The global biosimilar market is predicted to more than double in size to $19 billion by 2018. The increasing demand for our biosimilars services and the addition of several new clients has made this a necessary investment for 2014, as our revenues in this market have quadrupled in the last 18 months,” commented BioOutsource CEO, Gerry MacKay. “We are delighted to announce the opening of this new, state-of-the-art Biosimilar Centre of Excellence in Glasgow.”

The Biosimilar Centre of Excellence is located on the West of Scotland Science Park in Glasgow, adjacent to the existing BioOutsource facility. The new operation will consist of approximately 40 laboratory and R&D scientists creating an estimated 20 new jobs.

“We are committed to providing our clients with excellent levels of service and technical support” continued Mr. MacKay. “In 2013 we increased our headcount by 30% as we added new services to our portfolio and we anticipate repeating this expansion in the first quarter of this year. We have now worked with no fewer than 30 global biosimilar companies who use our range of off-the-shelf assays for the comparability, stability and lot release testing of their biosimilars.”

Mr. MacKay concluded, “Importantly, we feel that our growth in this fast emerging market is driven by our extensive investments in an R&D program, which is developed and refined in conjunction with all our global clients.”

About BioOutsource Ltd

BioOutsource provides contract testing services to the biopharmaceutical industry. Our core offering includes a comprehensive range of services to support the testing of Biologics, Vaccines & Biosimilars throughout their development. We possess an unparalleled combination of commercial, regulatory and technical knowledge that enables us to truly stand out as the industry’s increasingly preferred testing partner. We understand the importance of our service to support our client’s critical testing requirements and as a result, continually strive to provide a world class service globally.

Contacts
For BioOutsource:
Dr. Verna McErlane
Director of Sales & Marketing, Americas & Asia Pacific
BioOutsource, Ltd.
+ 44 (0) 141 946 4222
verna@biooutsource.com
or
Bill Douglass
Gotham Communications, LLC
1-646-504-0890
bill@gothamcomm.com

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES